Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 
Tweet this page
Share on Facebook
Share on Google+

7 Binary Options

 

Enter Stock Symbol:  

Glaukos Corp (GKOS)

30.31 0.56 (1.88%)

04-23 16:02

Open:

29.78

Pre. Close:

29.75

High:

30.49

Low:

29.78

Volume:

198,204

Market Cap:

1056M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

30.528 - 30.641

30.641 - 30.732

Low:

29.474 - 29.617

29.617 - 29.731

Close:

30.095 - 30.316

30.316 - 30.494

Technical analysis  (as of: 2018-04-23 4:29:46 PM)

Overall:

      

Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.

Target:

Six months: 37.11     One year: 40.74

Support:

Support1: 26.75    Support2: 22.26

Resistance:

Resistance1: 31.77    Resistance2: 34.88

Pivot:

30.43

Moving Averages:

MA(5): 29.76     MA(20): 30.46

MA(100): 29.37     MA(250): 34.21

MACD:

MACD(12,26): -0.47     Signal(12,26,9): -0.38

%K %D:

%K(14,3): 53.87     %D(3): 51.07

RSI:

RSI(14): 48.49

52-Week:

High: 48.89  Low: 23.075  Change(%): -35.0

Average Vol(K):

3-Month: 59091  10-Days 77812

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and NEUTRAL in mid-long term.
GKOS has closed above bottom band by 47.5%. Bollinger Bands are 19.2% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Headline News

2018-04-19T16:30:00-04:00
Glaukos Corporation to Release First Quarter 2018 Financial Results after Market Close on May 9

2018-04-16T12:45:41-04:00
Glaukos iStent reduces IOP in cataract surgery patients; shares up 3%

2018-04-14T15:30:00-04:00
IDE Pivotal Trial Results for Glaukos' iStent inject® Show Significant Reductions in Unmedicated IOP in Glaucoma Subjects Undergoing Cataract Surgery

2018-04-14T08:00:00-04:00
Glaukos Files Patent Infringement Lawsuit Against Ivantis, Inc.

2018-04-13T16:38:20-04:00
Alcon introduces streamlined ocular microstent system

2018-04-13T08:46:42-04:00
Stifel softens view on Glaukos, sees competitive inroads from Ivantis; shares slip 5% premarket

2018-04-13T08:06:51-04:00
Premarket analyst action - healthcare

2018-04-11T07:00:00-04:00
Multiple Surgeon Presentations to Include Glaukos Technologies at 2018 American Society of Cataract and Refractive Surgery

Financial Analysis

Growth

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Medical Devices Implants

Shares Out. (M)

34.83

Shares Float (M)

34.47

% Held by Insiders

% Held by Institutions

Shares Short (K)

5258

Shares Short Prior Month (K)

4460

Stock Financials

EPS

0.150

EPS Est. Current Year

-0.060

EPS Est. Next Year

0.230

EPS Est. Next Quarter

0.010

Forward EPS

0.030

Book Value (p.s.)

7.440

PEG Ratio

-2.19

Profit Margin

-0.79

Operating Margin

1.91

Return on Assets (ttm)

-0.1

Return on Equity (ttm)

-0.1

Qtrly Rev. Growth

25.6

Gross Profit (p.s.)

2.905

Sales Per Share

EBITDA (p.s.)

0.032

Qtrly Earnings Growth

650.70

Operating Cash Flow (M)

25.51

Levered Free Cash Flow (M)

22.30

atoplab.com

Valuation

P/E

202.07

P/E Growth Ratio

0.02

P/BV

4.07

P/S

227423200.00

P/CF

41.38

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.